ING Group’s Pediatrix Medical MD Stock Holding History

ING Group’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-13,264	Closed	-$335K	–	643
2019 Q2	$335K	Buy	+13,264	New	+$356K	0.01%	629
2018 Q3	–	Sell	-14,474	Closed	-$626K	–	817
2018 Q2	$626K	Buy	+14,474	New	+$694K	0.01%	412

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

ING Group's MD Position: Q3 2019 in Review

ING Group sold out of Pediatrix Medical (MD) in Q3 2019, closing a stake of 13,264 shares — an estimated $335K sold.

ING Group first reported a position in MD in Q2 2018 and held it in 2 quarters. The position peaked at $626K in Q2 2018. 223 funds tracked by Wall St. Rank hold MD as of Q3 2019.

ING Group reported no remaining Pediatrix Medical position as of Q3 2019 after selling out during the quarter.
ING Group sold 13,264 Pediatrix Medical shares in Q3 2019, an estimated $335K.
ING Group first reported a position in Pediatrix Medical in Q2 2018 and held it in 2 quarters.
ING Group's Pediatrix Medical position peaked at $626K in Q2 2018.
223 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2019.

Based on ING Group's 13F filing for Q3 2019, filed 8 Nov 2019.